About ELAHERE
ELAHERE is a Healthcare company based in Waltham (United States) founded in 2018, and was acquired by AbbVie in November 2023. Prescription medicine treats adults with folate receptor-alpha positive ovarian cancers. Its chief executive, as recorded, is Mark Enyedy. Its website elahere.com draws about 59 thousand monthly visits. Its focus areas include Pharmaceutical Product Websites. Its legal entity is ELAHERE Pharmaceuticals Inc.
Company details
ELAHERE was founded in 2018 and is based in Waltham, United States. Operations are focused on the pharmaceutical sector, particularly oncology. A prescription medicine is developed and provided to address folate receptor-alpha positive ovarian cancer, fallopian tube cancer, and primary peritoneal cancer in adults. The company is led by CEO Mark Enyedy, with activities centered on targeted cancer treatments. The domain elahere.com supports online information access.
- Headquarters Waltham, United States
- Stage Acquired
- SectorsHealthcare
- Website elahere.com
- Acquired by AbbVie (Nov 2023)
- Legal Name Elahere Pharmaceuticals Inc.
Investors in ELAHERE
ELAHERE has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include AbbVie.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Biopharmaceutical research and drug development are conducted globally by AbbVie. | 2012 | abbvie.com | Chicago, United States |
Investor details for ELAHERE
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of ELAHERE
1 people are tracked at ELAHERE (1 in leadership).
| Name | Role | Group |
|---|---|---|
Mark Enyedy | CEO | Leadership |
Complete people profiles for ELAHERE
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of ELAHERE
2 dated milestones of ELAHERE across 5 years, from founding to its latest funding, stage changes and deals.
- Founded ELAHERE is founded.
- Exit Acquired by AbbVie.
Web traffic of ELAHERE
The website of ELAHERE (elahere.com) receives about 59.1K visits a month.
- Monthly visits59.1K
▼ 1.2% vs previous month
Websites whose visitors overlap most with ELAHERE. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
xiidra-ecp.com | xiidra-ecp.com | 100% | #136,284 | – |
Top companies in Pharmacy & Healthcare Retail Systems
3 companies that operate in the same segment as ELAHERE (Pharmacy & Healthcare Retail Systems) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Alto Pharmacy is focused on providing convenient prescription delivery services. | 2015 | San Francisco, California, United States | USD 591.64 M | 802 | ||
Optum is recognized as a leading health solution and care delivery organization. | 2011 | Eden Prairie, Minnesota, United States | USD 250 K | USD 383.36 M | 140 | |
Materials management and business analytics solutions for healthcare are provided. | 1992 | Mountain View, California, United States | USD 20 M | USD 1.18 B | 3,670 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about ELAHERE
ELAHERE was founded in 2018.
ELAHERE is headquartered in Waltham, United States. It is registered at Waltham, Massachusetts, United States.
Mark Enyedy is the CEO of ELAHERE, as recorded in our data.
ELAHERE was founded in 2018 and is based in Waltham, United States. Operations are focused on the pharmaceutical sector, particularly oncology. A prescription medicine is developed and provided to address folate receptor-alpha positive ovarian cancer, fallopian tube cancer, and primary peritoneal cancer in adults. The company is led by CEO Mark Enyedy, with activities centered on targeted cancer treatments. The domain elahere.com supports online information access.
ELAHERE has 1 investor. Key investors include AbbVie.
ELAHERE operates through Elahere Pharmaceuticals Inc..
Yes. ELAHERE was acquired by AbbVie in November 2023.